Stay updated on BLU-5937 Dose Escalation in Chronic Cough Clinical Trial

Sign up to get notified when there's something new on the BLU-5937 Dose Escalation in Chronic Cough Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BLU-5937 Dose Escalation in Chronic Cough Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:32:41.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the number of patients who completed treatment in a dose escalation study of BLU-5937 for unexplained or refractory chronic cough.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:04.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying conditions such as unexplained or refractory chronic cough for at least one year and other health-related requirements.
    Difference
    23%
    Check dated 2024-05-22T20:57:11.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:31:40.000Z thumbnail image

Stay in the know with updates to BLU-5937 Dose Escalation in Chronic Cough Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BLU-5937 Dose Escalation in Chronic Cough Clinical Trial page.